RaySearch partners with Accuray for online adaptive radiation therapy
Accuray will pay USD 8 million for RayStation licenses to integrate software with Radixact and CyberKnife platforms, accelerating treatment adoption.
See the latest news and media coverage for RaySearch. We track all announcements, press releases, and industry mentions in real time, all in one place.
Radiation therapy and oncology software provider
raysearchlabs.comLast updated
In short: RaySearch reported record 2025 results but faced a Q2 2026 slowdown due to US order delays, while expanding its AI-driven software suite.
Accuray will pay USD 8 million for RayStation licenses to integrate software with Radixact and CyberKnife platforms, accelerating treatment adoption.
Order intake rose 23% to SEK 296 M, but net sales fell 11% to SEK 272 M, with EBIT down 23%. The company expects temporary setback and reaffirms its 2026 margin target.
The orders, worth about USD 5 million, were received from nine US customers including University of Florida Health and Emory Proton Therapy Center.
Net sales expected at SEK 272M, operating profit SEK 28M, order intake SEK 296M, and free cash flow SEK 50M.
An update from RaySearch Laboratories AB ( ($SE:RAY.B) ) is now available. RaySearch Laboratories AB and U.S.-based Accuray Incorporated have signed a definitive agreement to...
The medical technology company's CEO Johan Löf says that the growth and earnings development in the quarter was a disappointment.
Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.
Swedbank Robur Fonder has increased its holding in the medical technology company Raysearch and passed the flagging threshold of 5 percent of the share capital.
Track RaySearch and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to RaySearch and other trending companies.